Inotiv Inc
NOTV
Market Cap$76.26M
Close$
$-1.87
184.2% downside
Current Fair Value
184.2% downsideOvervalued by 184.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $76.26 Million |
|---|---|
| Enterprise Value | $105.31 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-4.19 |
| Beta | 4.1 |
| Outstanding Shares | 33,995,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.86 |
|---|---|
| PEG | 1.25 |
| Price to Sales | 0.16 |
| Price to Book Ratio | 0.56 |
| Enterprise Value to Revenue | 0.22 |
| Enterprise Value to EBIT | -1.39 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.46 |
| Debt to Equity | 0.31 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Inotiv Inc
409 employees
CEO: Jacqueline Lemke Bioanalytical Systems, Inc., operating as Inotiv, is a pharmaceutical development company providing contract research services and monitoring instruments to emerging pharmaceutical companies and the world's leading drug development compa...